Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Despite Recent Treatment With IV Bisphosphonates

NCT00896454 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00896454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00896454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Multicenter, Proof-of-concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Despite Recent Treatment With IV Bisphosphonates
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
November 16, 2009
Completion date
August 21, 2013
Enrollment
33 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colon cancer, endocrine cancer, head and neck cancer, hodgkin's lymphoma, hypercalcemia of malignancy, kidney cancer, lung cancer, lymphoma, metastatic cancer, multiple myeloma, non-hodgkin's lymphoma, non-small cell lung cancer, parathyroid neoplasms, renal cancer, thyroid cancer